Theseus Pharmaceuticals Inc (THRX) Key Ratios

Stock Card

$4.06

$0.00 (0.00%)

As on 23-Feb-2024 09:30EDT

Market cap

$181 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

0.8

Div. Yield

0 %

Key Ratios and Highlights

Growth Score (%)	Quarterly		Annual (TTM)
Particulars	QoQ	YoY	1-Year	3-Years	5-Years
Revenue	--	--	--	--	--
EBIT	6.61	-2.99	-40.88	-307.58	--
Net Profit	8.79	0.28	-27.44	-265.76	--
EPS	8.92	12.16	-15.13	--	--
Book Value	--	--	-21.90	--	--

Key Ratios (%)	Average		Annual (TTM)
Particulars	3-Years	5-Years	TTM	Dec-22	Dec-21
EBIT-Margin	--	--	--	--	--
Net Margin	-49,525.61	--	-778.31	-1,522.64	-97,528.57
Return on equity	2.82	--	-23.77	-20.74	-25.74
Return on Capital	2.88	--	--	-20.56	-25.74
Return on Assets	-93.30	--	-23.29	-19.89	-21.04
Debt to Equity (x)	--	--	0.00	0.02	--

Profitability

View Detailed Peer Comparison

ROCE

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	-20.56	-25.74	54.94	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROE

-23.77

Higher than Peers by 16.52

Profit after tax / Average Net worth * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-23.77	-20.74	-25.74	54.94	--
Peer Median	-40.29	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

ROA

-23.29

Higher than Peers by 7.55

Profit after tax / Average Total assets * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-23.29	-19.89	-21.04	-238.96	--
Peer Median	-30.84	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Margin

-778.31

Lower than Peers by 688.42

Net profit / Total Income (Net sales plus other income) * 100

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-778.31	-1,522.64	-97,528.57	--	--
Peer Median	-89.88	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-40.88

Lower than Peers by 39.92

Year on year growth in operating profit (EBIT)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-40.88	-97.86	-299.88	-38.32	--
Peer Median	-0.95	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Net Profit Growth

-27.44

Lower than Peers by 20.26

Year on year growth in profit after tax

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-27.44	-72.40	-127.62	-67.02	--
Peer Median	-7.19	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EPS Growth

-15.13

Lower than Peers by 29.56

Year on year growth in earnings per share

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-15.13	-0.60	-0.61	--	--
Peer Median	14.43	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Book Value Growth

-9.52

Higher than Peers by 0.94

Year on year growth in book value per share

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-9.52	--	--	--	--
Peer Median	-10.46	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

Total debt / Net worth

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	0.02	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Short term debt to equity ratio

0.00

(Short term borrowings / Net worth)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	0.00	0.00	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Current Ratio

29.93

Higher than Peers by 24.12

Current Assets / Current Liabilities and Provisions

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	29.93	17.79	67.38	5.37	2.25
Peer Median	5.80	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Quick Ratio

29.93

Higher than Peers by 24.23

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	29.93	--	--	--	--
Peer Median	5.69	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Interest Coverage

-12.53

Lower than Peers by 10.44

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	-12.53	-15.33	-976.29	--	--
Peer Median	-2.09	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

Sales / Average Total Assets

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	--	--	--	--
Peer Median	0.07	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Payable days

Average Creditors / Cost of goods sold * 365

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	2,491.29	194,860.88	129,389.81	52,048.13
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

Current share price divided by earning per share in the last twelve months

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	-4.09	-16.66	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Price / Book Value

0.81

Lower than Peers by 4.54

Current share price divided by book value per share in the latest financial year

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	0.81	0.93	1.85	--	--
Peer Median	5.35	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Dividend Yield

Dividend per share in the past twelve months divided by current share price

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	--	--	--	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

EV/EBITDA

0.30

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	0.30	0.02	-7.69	--	--
Peer Median	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Market Cap

181

Higher than Peers by 34

Current Share price multiplied by latest total number of shares outstanding

Company Name	TTM	Dec-22	Dec-21	Dec-20	Dec-19
Theseus Pharmaceuticals Inc (THRX)	181	--	--	--	--
Peer Median	147	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly